Correlation Between Mercedes-Benz Group and PDS Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mercedes-Benz Group and PDS Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mercedes-Benz Group and PDS Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mercedes Benz Group AG and PDS Biotechnology Corp, you can compare the effects of market volatilities on Mercedes-Benz Group and PDS Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mercedes-Benz Group with a short position of PDS Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mercedes-Benz Group and PDS Biotechnology.

Diversification Opportunities for Mercedes-Benz Group and PDS Biotechnology

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Mercedes-Benz and PDS is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Mercedes Benz Group AG and PDS Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PDS Biotechnology Corp and Mercedes-Benz Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mercedes Benz Group AG are associated (or correlated) with PDS Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PDS Biotechnology Corp has no effect on the direction of Mercedes-Benz Group i.e., Mercedes-Benz Group and PDS Biotechnology go up and down completely randomly.

Pair Corralation between Mercedes-Benz Group and PDS Biotechnology

Assuming the 90 days horizon Mercedes Benz Group AG is expected to generate 0.26 times more return on investment than PDS Biotechnology. However, Mercedes Benz Group AG is 3.79 times less risky than PDS Biotechnology. It trades about -0.01 of its potential returns per unit of risk. PDS Biotechnology Corp is currently generating about -0.04 per unit of risk. If you would invest  5,709  in Mercedes Benz Group AG on October 9, 2024 and sell it today you would lose (308.00) from holding Mercedes Benz Group AG or give up 5.39% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy99.6%
ValuesDaily Returns

Mercedes Benz Group AG  vs.  PDS Biotechnology Corp

 Performance 
       Timeline  
Mercedes Benz Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mercedes Benz Group AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Mercedes-Benz Group is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
PDS Biotechnology Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Mercedes-Benz Group and PDS Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mercedes-Benz Group and PDS Biotechnology

The main advantage of trading using opposite Mercedes-Benz Group and PDS Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mercedes-Benz Group position performs unexpectedly, PDS Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PDS Biotechnology will offset losses from the drop in PDS Biotechnology's long position.
The idea behind Mercedes Benz Group AG and PDS Biotechnology Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets